Stocks
Halozyme (HALO) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 58.4% | 47.8% | 54.5% | 64.7% | 41.0% | 63.7% | ||
| Changes by years, y/y, % | +1pp | -11pp | +7pp | +10pp | -24pp | -6.4% | |||
Halozyme. EBITDA margin, %
Halozyme. EBITDA margin, changes, pp
Halozyme (HALO) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 70.5% | 68.8% | -15.3% | 58.3% | 66.5% | 63.7% | |
| Changes by years, y/y, % | +11pp | +3pp | -84pp | -3pp | -4pp | |||
| Changes by quarters, q/q, % | +9pp | -2pp | -84pp | +74pp | +8pp | |||
